Ahmad, S. (1996). Losartan and reversible psychosis. Cardiology, 87, 569–570.
Alexopoulos, G. S. (2003). Vascular disease, depression, and dementia. Journal of the American Geriatrics Society, 15, 1178–1180.
American Psychiatric Association (1987). Diagnostic and Statistical Manual of Mental Disorders (3rd edn, revised). Washington, DC: American Psychiatric Association.
Angelelli, P. et al. (2004). Development of neuropsychiatric symptoms in poststroke patients: A cross-sectional study. Acta Psychiatrica Scandinavica, 110, 55–63.
Ballard, C., Bannister, C., Solis, M., Oyebode, F. and Wilcock, G. (1996). The prevalence, associations and symptoms of depression amongst dementia sufferers. Journal of Affective Disorders, 36, 135–144.
Ballard, C., Neill, D., O'Brien, J., McKeith, I. G., Ince, P. and Perry, R. (2000). Anxiety, depression and psychosis in VaD: prevalence and associations. Journal of Affective Disorders, 59, 97–106.
Bassiony, M. M., Steinberg, M. S., Warren, A., Rosenblatt, A., Baker, A. S. and Lyketsos, C. G. (2000). Delusions and hallucinations in AD: prevalence and clinical correlates. International Journal of Geriatric Psychiatry, 15, 99–107.
Beeri, M. S., Werner, P., Davidson, M. and Noy, S. (2002). The cost of behavioral and psychological symptoms of dementia (BPSD) in community dwelling AD patients. International Journal of Geriatric Psychiatry, 17, 403–408.
Boyle, P. A., Malloy, P. F., Salloway, S., Cahn-Weiner, D. A., Cohen, R. and Cummings, J. L. (2003). Executive dysfunction and apathy predict functional impairment in Alzheimer's disease. American Journal of Geriatric Psychiatry, 11, 214–221.
Breitner, J. C. et al. (1999). APOE-epsilon4 count predicts age when prevalence of AD increases, then declines: the Cache County Study. Neurology, 53, 321–331.
Brodaty, H. et al. (2001). Psychosis, depression and behavioural disturbances in Sydney nursing home residents: prevalence and predictors. International Journal of Geriatric Psychiatry, 16, 504–512.
Chan, D. C., Kasper, J. D., Black, B. S. and Rabins, P. V. (2003). Prevalence and correlates of behavioral and psychiatric symptoms in community-dwelling elders with dementia or mild cognitive impairment: the Memory and Medical Care Study. International Journal of Geriatric Psychiatry, 18, 174–182.
Copeland, M. P. et al. (2003). Psychiatric symptomatology and prodromal AD. Alzheimer Disease and Associated Disorders, 17, 1–8.
Craig, A. H. et al. (1996). Cerebral blood flow correlates of apathy in Alzheimer's disease. Archives of Neurology, 53, 1116–1120.
Craig, D., Hart, D. J., McCool, K., McIlroy, S. P. and Passmore, A. P. (2004). Apolipoprotein E ε4 allele influences aggressive behaviour in Alzheimer's disease. Journal of Neurology, Neurosurgery, and Psychiatry, 75, 1327–1330.
Craig, D., Mirakhur, A., Hart, D. J., McIlroy, S. P. and Passmore, A. P. (2005). A cross-sectional study of neuropsyhiatric symptoms in 435 patients with Alzheimer's disease. American Journal of Geriatric Psychiatry, 13, 460–468.
Cummings, J. L., Mega, M., Gray, K., Rosenberg-Thompson, S., Carusi, D. A. and Gornbein, J. (1994). The neuropsychiatric inventory. Comprehensive assessment of psychopathology in dementia. Neurology, 24, 2308–2314.
Danhauer, S. C., McCann, J. J., Gilley, D. W., Beckett, L. A., Bienias, J. L. and Evans, D. A. (2004). Do behavioral disturbances in persons with Alzheimer's disease predict caregiver depression over time? Psychology and Aging, 19, 198–202.
Ferretti, L., McCurry, S. M., Logsdon, R., Gibbons, L. and Teri, L. (2001). Anxiety and AD. Journal of Geriatric Psychiatry and Neurology, 14, 52–58.
Finkel, S. (2000). Introduction to behavioural and psychological symptoms of dementia (BPSD). International Journal of Geriatric Psychiatry, 15, S2–S4.
Gabryelewicz, T. et al. (2002). Behavioural pathology in AD with special reference to Apolipoprotein E genotype. Dementia and Geriatric Cognitive Disorders, 14, 208–212.
Geroldi, C. et al. (2000). Temporal lobe asymmetry in patients with Alzheimer's disease with delusions. Journal of Neurology, Neurosurgery, and Psychiatry, 69, 197–191.
Gilley, D. W., Wilson, R. S., Bienias, J. L., Bennett, D. A. and Evans, D. A. (2004). Predictors of depressive symptoms in persons with AD. Journal of Gerontology, 59B, P75–P83.
Hargrave, R., Geck, L. C., Reed, B. and Mungas, D. (2000). Affective behavioural disturbances in Alzheimer's disease and ischaemic vascular disease. Journal of Neurology, Neurosurgery, and Psychiatry, 68, 41–46.
Harwood, D. G., Barker, W. W., Ownby, R. L. and Duara, R. (2000). Clinical characteristics of community-dwelling black AD patients. Journal of the National Medical Association, 92, 424–429.
Hayden, K. M. et al. (2006). Vascular risk factors for incident Alzheimer disease and vascular dementia. The Cache County Study. Alzheimer Disease and Associated Disorders, 20, 93–100.
Hirono, N. et al. (1999). Lack of effect of apolipoprotein E ε4 allele on neuropsychiatric manifestations in Alzheimer's disease. Journal of Neuropsychiatry and Clinical Neurosciences, 11, 66–70.
Holtzer, R. et al. (2003). Psychopathological features in AD: course and relationship with cognitive status. Journal of the American Geriatrics Society, 51, 953–960.
Hughes, C. P., Berg, L., Danziger, W. L., Coben, L. A. and Martin, R. L. (1982). A new clinical scale for the staging of dementia. British Journal of Psychiatry, 140, 566–572.
Ikeda, M. et al. (2004). Dementia associated mental and behavioural disturbances in elderly people in the community: findings from the first Nakayama study. Journal of Neurology, Neurosurgery and Psychiatry, 75, 146–148.
Iverson, G. L., Hopp, G. A., DeWolfe, K. and Solomons, K. (2002). Measuring change in psychiatric symptoms using the Neuropsychiatric Inventory – Nursing Home version. International Journal of Geriatric Psychiatry, 17, 438–443.
Jorm, J. and Jacomb, P. (1989). The Informant Questionnaire on Cognitive Decline in the Elderly (IQCODE): socio-demographic correlates, reliability, validity and some norms. Psychological Medicine, 19, 1015–1022.
Khachaturian, A. S., Gallo, J. J., and Breitner, J. C. S. (2000). Performance characteristics of a two-stage dementia screen in a population sample. Journal of Clinical Epidemiology, 53, 531–540.
Leroi, I., Voulgari, A., Breitner, J. C. S. and Lyketsos, C. G. (2003). The epidemiology of psychosis in dementia. American Journal of Geriatric Psychiatry, 11, 83–91.
Levy, M. L., Cummings, J. L., Fairbanks, L. A., Sultzer, D. L. and Small, G. W. (1999). Apolipoprotein E genotype and noncognitive symptoms in Alzheimer's disease. Biological Psychiatry, 45, 422–425.
Lopez, O. L., Smith, G., Becker, J. T., Meltzer, C. C. and DeKosky, S. T. (2001). The psychotic phenomenon in probable Alzheimer's disease: a positron emission tomography study. Journal of Neuropsychiatry and Clinical Neurosciences, 13, 50–55.
Lopez, O. L. et al. (2003). Psychiatric symptoms vary with the severity of dementia in probable AD. Journal of Neuropsychiatry and Clinical Neurosciences, 15, 346–353.
Lyketsos, C. G. et al. (1999). The General Medical Health Rating (GMHR): a bedside global rating of medical comorbidity in patients with dementia. Journal of the American Geriatrics Society, 47, 487–491.
Lyketsos, C. G., Steinberg, M., Tschanz, J. T., Norton, M. C., Steffens, D. C. and Breitner, J. C. (2000). Mental and behavioral disturbances in dementia: findings from the Cache County Study on Memory in Aging. American Journal of Psychiatry, 157, 708–714.
Lyketsos, C. G. et al. (2001). Neuropsychiatric disturbances in Alzheimer's disease clusters into three groups: the Cache County study. International Journal of Geriatric Psychiatry, 16, 1043–1053.
Lyketsos, C. G. et al. (2005). Population-based study of medical comorbidity in early dementia and “cognitive impairment, no dementia (CIND)”: association with functional and cognitive impairment: the Cache County Study. American Journal of Geriatric Psychiatry, 13, 656–664.
McKhann, G., Drachman, D., Folstein, M., Katzman, R., Price, D. and Stadlan, E. M. (1984). Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of the Department of Health and Human Services Task Force on Alzheimer's disease. Neurology, 34, 939–944.
McLaughlin, T., Geissler, E. C. and Wan, G. J. (2003). Comorbidities and associated treatment charges in patients with anxiety disorders. Pharmacotherapy, 23, 1251–1256.
Mehta, K. M. et al. (2003). Prevalence and correlates of anxiety symptoms in well-functioning older adults: findings from the health aging and body composition study. Journal of the American Geriatrics Society, 51, 499–504.
Miech, R., Breitner, J., Zandi, P., Khachaturian, A., Anthony, J. C. and Mayer, L. (2002). Incidence of AD may decline in the early 90s for men, later for women: the Cache County study. Neurology, 58, 209–218.
Morris, J. C. et al. (1997). Clinical Dementia Rating training and reliability in multicenter studies: the Alzheimer's Disease Cooperative Study experience. Neurology, 48, 1508–1510.
O'Brien, J., Perry, R., Barber, R., Gholkar, A. and Thomas, A. (2000). The association between white matter lesions on magnetic resonance imaging and noncognitive symptoms. Annals of the New York Academy of Sciences, 903, 482–489.
Okada, K., Kobayashi, S., Yamagata, S., Takahashi, K. and Yamaguchi, S. (1997). Poststroke apathy and regional cerebral blood flow. Stroke, 28, 2437–2441.
Paulsen, J. S. et al. (2000). Incidence of and risk factors for hallucinations and delusions in patients with probable AD. Neurology, 54, 1965–1971.
Silverman, J. M., Breitner, J. C. S., Mohs, R. C. and Davis, K. L. (1986). Reliability of the family history method in genetic studies of Alzheimer's disease and related dementias. American Journal of Psychiatry, 143, 1279–1282.
Starkstein, S. E. et al. (1997). Neuropsychological, psychiatric, and cerebral perfusion correlates of leukoaraiosis in AD. Journal of Neurology, Neurosurgery, and Psychiatry, 63, 66–76.
Starkstein, S. E., Petracca, G., Chemerinski, E. and Kremer, J. (2001). Syndromic validity of apathy in AD. American Journal of Psychiatry, 158, 872–877.
Starkstein, S. E., Jorge, R., Mizrahi, R. and Robinson, R. G. (2006). A prospective longitudinal study of apathy in Alzheimer's disease. Journal of Neurology, Neurosurgery, and Psychiatry, 77, 8–11.
Steinberg, M. et al. (2006). Risk factors for neuropsychiatric symptoms in dementia: the Cache County Study. International Journal of Geriatric Psychiatry, 21, 824–830.
Tran, P. et al. (2006). Neuropsychiatric symptoms and medical illness in patients with dementia: an exploratory study. Journal of the American Osteopathic Association, 106, 412–414.
Tsai, S. J., Hwang, J. P., Yang, C. H. and Liu, K. M. (1996). Physical aggression and associated factors in probable AD. Alzheimer Disease and Associated Disorders, 10, 82–85.
Tschanz, J., Welsh-Bohmer, K., Plassman, B., Norton, M., Wyse, B. and Breitner, J. (2002). An adaptation of the Modified Mini-Mental State Examination: analysis of demographic influences and normative data. The Cache County Study. Neuropsychiatry, Neuropsychology, and Behavioral Neurology, 58, 28–38.
van der Flier, W. M. et al. (2007). Apolipoprotein E genotype influences presence and severity of delusions and aggressive behavior in Alzheimer disease. Dementia and Geriatric Cognitive Disorders, 23, 42–46.